Novartis Farma – Produtos Farmacêuticos S.A.
Category(ies): Biotech Companies; Medtech Companies; Pharmaceutical Companies
Address: Avenida Professor Doutor Cavaco Silva, N.º 10E, Taguspark; 2740-255 Porto Salvo; Portugal
Keyword(s): Cancer, Cell Biology, Metabolic Disorders, Neurology, Pharmaceuticals
Novartis is a pharmaceutical company, based in Basel, Switzerland, leader in innovative solutions designed to meet the healthcare needs of patients and society. Novartis was created in 1996, resulting from the merger between Ciba-Geigy and Sandoz, two companies with extensive corporate history going back more than 70 years in Portugal. This sustained presence contribuited to build the identity of Novartis Portugal and ground the strong commitment the company assumes with the country. The Novartis Pharmaceuticals Division is internationally recognised its development and introduction for its portfolio of innovative medicines, services and solutions that it brings to patients, doctors and healthcare organizations. Its researchers aspire to bring the best treatment options for the right patient, at the right time. In 2014, R&D activities Portugal developed by Novartisn in partnership with national healthcare and research institutions represented an investment of 9.8 million euros. Namely, there are currently 37 active Clinical Trials 37 ongoing, involving 600 patients in about 190 local centres in 40 institutions, and contributed to about 110 scientific publications. Today, about 50 Novartis employees are exclusively dedicated to R&D.
Public Affairs & Market Access Head
+351 210 008 629
+351 912 249 262